Ron Frieson - Nov 1, 2021 Form 3 Insider Report for Akebia Therapeutics, Inc. (AKBA)

Role
Director
Signature
/s/ Carolyn Rucci, attorney-in-fact for Ronald E. Frieson
Stock symbol
AKBA
Transactions as of
Nov 1, 2021
Transactions value $
$0
Form type
3
Date filed
11/3/2021, 04:45 PM
Next filing
Jun 9, 2022

No securities are beneficially owned.